Cryptosporidium: from molecules to disease

R C Andrew Thompson; Rachel M Chalmers

doi:10.1016/s1471-4922(01)02232-2

Cryptosporidium: from molecules to disease

Trends Parasitol. 2002 Mar;18(3):98-100. doi: 10.1016/s1471-4922(01)02232-2.

Authors

R C Andrew Thompson¹, Rachel M Chalmers

Affiliation

¹ Division of Veterinary and Biomedical Sciences, Murdoch University, Western Australia, Australia. andrew_t@numbat.murdoch.edu.au

PMID: 11854076
DOI: 10.1016/s1471-4922(01)02232-2

Abstract

The international conference, Cryptosporidium: from molecules to disease, was held 7-12 October 2001, in Fremantle, Western Australia, to discuss all aspects of Cryptosporidium and cryptosporidiosis.

Publication types

Congress
Research Support, Non-U.S. Gov't

MeSH terms

Animals
Coccidiostats / therapeutic use*
Cryptosporidiosis* / drug therapy
Cryptosporidiosis* / epidemiology
Cryptosporidiosis* / prevention & control
Cryptosporidium / drug effects
Cryptosporidium / growth & development
Cryptosporidium / physiology*
Humans
Oocytes
Research
Species Specificity
Treatment Outcome
Zoonoses

Substances

Coccidiostats